TOKYO/MUMBAI -- The global pharmaceutical industry is bracing for major supply chain disruptions as the Trump administration explores new tariffs on the sector, with producers of generic treatments in India and elsewhere seen suffering a particularly heavy blow.
Pharmaceuticals
India's generic drug industry feels pressure of Trump tariff threat
Pharma giants like Bayer, Takeda also weigh supply chain risks
.JPG?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto)
Tariffs would push up the price of generic drugs, used by many Americans to manage common conditions like high blood pressure. © Reuters
Read Next
Latest on Pharmaceuticals
